Crinetics announces the randomization of the first patient in a Phase 3 trial of an investigational treatment being studied in adults with carcinoid syndrome due to well-differentiated neuroendocrine tumors. Read more: https://bit.ly/3X6kKcn
Crinetics Pharmaceuticals
Pharmaceutical Manufacturing
San Diego, California 42,417 followers
Driving the next generation of endocrinology care. #Crinetics #Acromegaly #CarcinoidSyndrome
About us
We are a global pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for endocrine disease and endocrine-related tumors. Driven by the belief that no one should be defined by their disease, we’re transforming endocrine care to significantly improve the lives of patients, caregivers, and loved ones. As the premier, endocrine-rooted pharmaceutical company, we’re shaping the future of treatment, empowering individuals to live beyond their condition, and thrive. For information on our social media guidelines, please visit: https://crinetics.com/social-media-community-guidelines/ Notice of Fraudulent Activity for Job Applicants: Please be aware of fraudulent communications you might receive from job posting sites or via email. Bad actors may try to impersonate Crinetics’ Talent Acquisition team, and their messages may appear legitimate. We strongly recommend that you verify all communications you receive about positions at Crinetics. If you are unsure about a posting or email you receive, please contact us at talentacquisition@crinetics.com. If you believe you are a victim of fraud, please contact your local law enforcement.
- Website
-
https://crinetics.com
External link for Crinetics Pharmaceuticals
- Industry
- Pharmaceutical Manufacturing
- Company size
- 501-1,000 employees
- Headquarters
- San Diego, California
- Type
- Public Company
- Founded
- 2008
- Specialties
- Pharmaceuticals, Endocrinology, and Drug Development
Locations
-
Primary
Get directions
6055 Lusk Blvd
San Diego, California 92121, US
Employees at Crinetics Pharmaceuticals
Updates
-
This Veterans Day, we proudly recognize our very own Bill Branch, who served 26 years in the U.S. Marine Corps Reserve, leading with trust, teamwork, and purpose. Today, he brings that same dedication and leadership to his role as Director of Federal & State Government Accounts at Crinetics. We salute Bill and all those who’ve served for their strength, sacrifice, and commitment to something greater than themselves. #VeteransDay
-
This World NETs Cancer Day, we reaffirm our commitment to people living with neuroendocrine tumors (NETs). We were proud to meet with clinical leaders and patient advocacy partners in the NETs space at the recent NANETs meeting to explore how we can continue advancing science for those impacted by NETs. Learn more about how we’re driving innovating in this space: https://bit.ly/3XbsFVK #WorldNETsDay #NeuroendocrineTumors
-
-
Today we announced our 3Q2025 financial results. Read more about our updates and listen to the webcast live: https://bit.ly/47vdEEk
-
-
We're excited to share that results from our PATHFNDR-2 study in acromegaly are now published online in JCEM. https://lnkd.in/g9kVSMFX
-
At this year’s NANETS meeting, new data highlights progress for those with carcinoid syndrome. Hear from our Global Product Lead, Tom Beveridge, on how advancing the science of somatostatin receptor agonism is shaping the future of care: https://lnkd.in/gCaVgwnZ
-
-
We’re excited to be attending the 2025 North American Neuroendocrine Tumor Society Annual Meeting. Read more about our involvement: https://bit.ly/3JmXUtP
-
-
Say hello to Guapo! 🐾 Living up to his name, Guapo is Torrie Plata’s handsome pup who loves bringing joy, cuddles, and a little extra sunshine to the office. We’re proud to be a workplace where dogs are part of our pack, wagging tails included: https://bit.ly/3BmigiR #CrineticsCanines